IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

DSM Fine Chemicals and Relypsa sign API manufacturing agreement

6:36 AM MDT | May 20, 2014 | Deepti Ramesh

Pharmaceutical company Relypsa (Redwood City, CA) says that it has entered into a multi-year commercial manufacturing and supply agreement with DSM Fine Chemicals for the active pharmaceutical ingredient (API) for patiromer, the company's novel polymer in development for the treatment of hyperkalemia. DSM Fine Chemicals is a business unit of the newly formed DPx Holdings (Durham, NC). Earlier this year, DSM and private equity firm JLL Partners (New York) created DPx Holdings by combining DSM Pharmaceutical Products (Parsippany, NJ), the custom manufacturing and...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa